Shots: Regeneron will be responsible to deliver treatment doses for six years post-approval of product from the FDA, will receive compensation of ~$10M & average of $67M/year in 2021 and […]readmore
Tags : BARDA
1. LEO Reports the US FDA’s Acceptance of BLA for Tralokinumab to Treat Adults with Moderate to Severe Atopic Dermatitis Published Date: Jul 10, 2020 | Tags: LEO, Reports, US, […]readmore
Shots: Regeneron and the US Government signed $450M contract for the supply of REGN-COV2 which is currently in two P-II/III clinical trials for the treatment and in a P-III trial […]readmore
The emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies, as well as government agencies, to partner at unprecedented speed to develop […]readmore
Shots: The $1B support is for the development, production and delivery of the vaccine with its initiation in H2’20 including a P-III trial with 30,000 participants and a pediatric trial.AZ […]readmore
1. Sinovac Initiates the P-I Clinical Study for Vaccine Candidate Against COVID-19 Published: Apr 17, 2020 | Tags: Sinovac, Initiates, P-I, Clinical Study, Vaccine Candidate, Against, COVID-19 2. 1Health.io Launches Self-Collection […]readmore
Shots: BARDA will fund ~$483M for the advancement of mRNA-1273 to FDA licensure. The funding will scale-up the manufacturing process and enables a large-scale production in 2020 while Moderna plans […]readmore
Shots: The collaboration follows the existing partnership b/w J&J and BARDA while the company expects to initiate the clinical studies of selected vaccine candidates by Sept’2020 with the anticipated first […]readmore
Shots: The P-III COVACTA study will evaluate the safety and efficacy of Actemra/RoActemra (tocilizumab) + SOC vs PBO + SOC in adult hospitalized patients with severe COVID-19 pneumonia The study […]readmore
Shots: The public-private collaboration will expand Janssen’s ongoing work with global partners to screen a library of existing antiviral molecules, with the goal to identify compounds with antiviral activity against […]readmore